Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Prana receives U.K. clearance for PLACQUE study of PBT-1 for Alzheimer's

Jan. 10, 2005

Ropinirole improves restless legs syndrome symptoms

Jan. 10, 2005

Olanzapine reported to reduce the risk of violent behavior in schizophrenia

Jan. 5, 2005

Preclinical and clinical studies evaluate the effects of interferon alpha on CNS

Jan. 5, 2005

FDA approves new oral solution formulation of Abilify

Jan. 5, 2005

CRF receptor antagonists for depression, anxiety, etc.

Jan. 5, 2005

Heparin sulphate mimetics prolong survival of laboratory animals with prion diseases

Jan. 4, 2005

Novel H3 antagonist demonstrates wake-promoting effects

Jan. 4, 2005

Donepezil reported to improve cognition and memory in early-stage Alzheimer's disease

Jan. 4, 2005

New River and Shire sign letter of intent for ADHD drug NRP-104

Jan. 4, 2005

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...